文献速递腹部MRCT

扩散加权成像与纹理分析:在弥漫性肝病中的当前作用

Diffusion-weighted imaging and texture analysis: current role for diffuse liver disease.
PubMed 文献 · Abdom Radiol (NY) · 2020-10-16

本文综述了扩散加权成像(DWI)和纹理分析在弥漫性肝病评估中的作用。DWI基于水分子运动模式评估组织微观结构改变,有望成为无创虚拟活检;纹理分析通过量化空间关系评估早期和晚期弥漫性肝病,初步结果显示出很大前景。

要点

  • DWI可评估肝纤维化等弥漫性肝病的组织微观结构改变。
  • DWI具有三维成像能力,可克服采样偏差。
  • 纹理分析可量化空间关系,初步结果前景良好。

核心结论

  • DWI有潜力成为评估弥漫性肝病的无创、非破坏性虚拟活检。
  • 纹理分析在评估早期和晚期弥漫性肝病方面初步结果显示出很大前景。

研究设计与样本

  • 综述,回顾DWI和纹理分析在MR图像评估弥漫性肝病中的作用。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Multiparametric MRI represents the primary imaging modality to assess diffuse liver disease, both in a qualitative and in a quantitative manner. Diffusion-weighted imaging (DWI) is among the imaging techniques that can be used to assess fibrosis due to its unique capability to assess microstructural changes at the tissue level. DWI is based on water mobility patterns and has the potential to become a non-invasive and non-destructive virtual biopsy to assess diffuse liver disease, overcoming sampling bias errors due to its three-dimensional imaging capabilities. Parallel to DWI, another quantitative method called texture analysis may be used to assess early and advanced diffused liver disease through quantifying spatial relationships in a global and local level, applying to any type of digital imaging technique like MRI or CT. Initial results using texture analysis hold great promise. In the current paper, we will review the role of DWI and texture analysis using MR images in assessing diffuse liver disease.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Gourtsoyianni S, Santinha J, Matos C, et al. Diffusion-weighted imaging and texture analysis: current role for diffuse liver disease. Abdom Radiol (NY). 2020. PMID: 33064169. doi:10.1007/s00261-020-02772-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。